Chayet & Danzo, LLC

Call for a Free Initial Consultation

Direct 303-872-5980
Toll-Free 888-472-1088
Email Us

COVID-19 NOTICE:

After careful review of the COVID-19 environment, the law firm of Chayet & Danzo, LLC, will be conducting in-person appointments in our offices on a limited basis and with strict social distancing protocols.

During this time, our team will continue to diligently work remotely on all client matters and will maintain communication through email, telephone, and video conferencing. Our main office number, (303) 355-8500 will continue to be answered during our normal business hours of 8:00 a.m. to 5 p.m. Monday – Thursday and 8:00 a.m. to 4:00 p.m. on Fridays.

This decision to have limited appointments in-office while following strict social distancing protocols is in the best interest and health of our team, clients and community.

We will continue accepting new clients during this period as well as fully servicing our existing clients.

We wish you and your family continued health during these unique and challenging times.

Compassion, talent and dedication:
guiding colorado families and Their Trusted Advisors During Times of Need

Alzheimer’s disease may soon be detectable through a blood test

| Nov 12, 2019 | Elder Law |

The findings of a recent study involving 158 older adults appeared in the journal Neurology in October. Results strongly suggest that a blood test may soon help to identify Alzheimer’s disease in patients at an early stage, according to the Fisher Center for Alzheimer’s Research Foundation. The test may allow doctors to determine with a very high likelihood that patients have the disease even before symptoms develop.

The hope is that medical researchers can develop new treatments to slow down and fight the disease while the brain is still healthier than it will become as the illness progresses. Part of this research would be to include people whose bloodwork indicates a high likelihood of Alzheimer’s in clinical trials earlier than is possible now.

The blood test determines whether the protein beta-amyloid is present. This toxic protein builds up within brain tissue of Alzheimer’s patients many years before outward symptoms of memory loss begin to manifest.

Researchers also considered patient age and the presence of APOE-E4, a gene that raises the person’s chances of developing Alzheimer’s. Using these three factors, researchers found that early diagnosis could be made with an accuracy rate of 94%.

Currently, doctors use PET brain scans to detect beta-amyloid. These scans are expensive, and their interpretation requires a high level of expertise. Should the blood test become routine, it would be relatively inexpensive, quicker and more easily interpreted.

Early detection would mean a patient could receive medications and other treatments well before severe brain damage, increasing the chance that the treatment could impact brain health.

At our law firm, we represent people with Alzheimer’s disease and other dementias as well as their loved ones and people with professional responsibilities for the well-being of vulnerable adults. Such professionals include guardians, conservators and trustees. We help with appropriate estate planning, trusts, Medicaid and other long-term care planning, public benefit preservation, location of the right residential facility or in-home services, detection of abuse or neglect and pursuit of legal remedies for resulting harm, and other legal services.

We hope that this research brings us closer to earlier and faster diagnosis of Alzheimer’s, which could greatly help our clients and their families.

 

 

 

                                                                               

Archives

Co-Counsel Services for
settling of Personal Injury and Divorce Cases

Read More

Important intake forms

Prepare for your Meeting

Our Elder Law & Estate Planning Blog

Read Weekly Updates

Join our mailing list

Sign up here

FindLaw Network